The Mediterranean diet and cardiovascular disease
Cardiovascular Research · 18.12.2025 · 121 (16) · 2465-2475
DOI: 10.1093/cvr/cvaf218 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 10.11.2025. Verfasst von María Barbería-Latasa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, 31008 Pamplona, Spain. Hauptthemen laut MEDLINE: Diet, Mediterranean, Cardiovascular Diseases, Diet, Healthy, Risk Reduction Behavior. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Health, Instituto de Salud Carlos III, PREDIMED Network.
Abstract (Originalsprache)
Since the 1950s, when Ancel Keys popularized the traditional Mediterranean diet, an immense accrual of large and valid studies, including prospective cohort studies, randomized controlled trials (RCT), and systematic reviews, have been conducted to investigate the potential health benefits related to this dietary pattern. The available evidence shows that the traditional Mediterranean diet represents a sustainable, healthy, and highly palatable pattern with a wide array of associated health benefits. In particular, its protective effects on cardiovascular disease have been supported by several consistent large RCTs, namely, the Lyon Diet-Heart Study, PREDIMED, PREDIMED-Plus and CORDIOPREV. The traditional Mediterranean diet is not a vegetarian diet, but it emphasizes the preferential consumption of minimally processed plant-based foods: fruits, vegetables, whole-grain cereals, legumes, and tree nuts. Its unique components—different from other healthy, plant-based, food patterns—are extra-virgin olive oil as the main source of fat (keeping a high monounsaturated-to-saturated fat ratio), a high consumption of tree nuts, and low-to-moderate consumption of red wine with meals. However, the inclusion of an alcoholic beverage in a healthy diet is becoming increasingly controversial. An ongoing RCT, the University of Navarra Alumni Trialist Initiative (UNATI), aims to answer this question in 10 000 drinkers. In addition to conventional epidemiologic studies, metabolomics techniques have been applied to assess the role of adherence to the Mediterranean diet and to better understand the mechanisms involved in the protection afforded by this interesting dietary pattern. In this review, we update the available scientific evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, 31008 Pamplona, Spain.
- Department of Preventive Medicine and Public Health, University of Navarra, Irunlarrea 1, Pamplona 31008, Spain.
- Biomedical Research Network Center for Pathophysiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
- Department of Nutrition, Harvard TH Chan School of Public Health, Boston.
ORCID-Profile: María Barbería-Latasa, Miguel A Martínez-González
Förderung
- Spanish Ministry of Health
- Instituto de Salud Carlos III
- PREDIMED Network
- MAM-G
- Ministerio de Economía y Competitividad
- Fondo Europeo de Desarrollo Regional
- CIBER Fisiopatología de la Obesidad y Nutrición
- European Regional Development Fund
Zitieren
APA
Barbería-Latasa, M., & Martínez-González, M. A. (2025). The Mediterranean diet and cardiovascular disease. Cardiovascular Research, 121(16), 2465-2475. https://doi.org/10.1093/cvr/cvaf218
Vancouver
Barbería-Latasa M, Martínez-González MA. The Mediterranean diet and cardiovascular disease. Cardiovascular Research. 2025;121(16):2465-2475. doi:10.1093/cvr/cvaf218
BibTeX
@article{BarberaLatasa2025,
author = {Barbería-Latasa, María and Martínez-González, Miguel A},
title = {The Mediterranean diet and cardiovascular disease},
journal = {Cardiovascular Research},
year = {2025},
volume = {121},
number = {16},
pages = {2465--2475},
doi = {10.1093/cvr/cvaf218}
}
EUVIMED